Medifarma Bolivia joins the global humanova holding
Medifarma Bolivia, a leading pharmaceutical company in the sector, has announced the beginning of a strategic transformation through its official integration into the global humanova holding. This milestone marks the company’s evolution towards a consolidated international structure, unifying its operations under a single vision and organizational culture.
The creation of humanova responds to the group’s sustained growth and its need to project a unified corporate identity across its nine operating markets. With a direct presence in nine countries and a reach spanning more than 50 markets, the holding is driven by a clear purpose: to transform global health and expand access to high-quality products.
“humanova was created to transform the health of the world we envision, driving solutions that improve quality of life through innovation and operational excellence,” stated Carlos Noriega, Country Manager in Bolivia.
This integration strengthens the corporation’s manufacturing capabilities and builds on its longstanding trajectory, aligning core values such as integrity, culture, collaboration, and agility. It also reinforces its commitment to expanding access to high-quality medicines, while promoting innovation, research, and the development of solutions that enhance people’s health and quality of life.
Regional Impact and Consolidation in Bolivia
The integration holds particular significance in key markets such as Bolivia, where the company has maintained an uninterrupted presence since 2008—initially as Hersil, later as Medifarma, and now under the humanova brand. In the country, the company manages highly trusted medical brands such as PVM, Topicrem, Magal D, Maddre, and Osteovit.
With a portfolio of nearly 1,000 registered products and manufacturing facilities operating under international Good Manufacturing Practices (GMP) standards, Medifarma–humanova is strengthening its distribution network across public, private, and retail channels to serve hospitals, clinics, and pharmacies throughout Latin America.
This new phase not only consolidates Medifarma–humanova regional leadership, but also positions the organization as a global player capable of addressing the current challenges of the pharmaceutical industry through research and the development of innovative health and wellness solutions.
About Medifarma – humanova
Medifarma, fundada en 1975, es una compañía farmacéutica de origen peruano, dedicada al desarrollo, fabricación y comercialización de medicamentos. Tras la integración de sus nueve operaciones, humanova forma parte de un ecosistema global que impacta la salud de millones de personas en más de 50 mercados internacionales, manteniendo su compromiso con la calidad y la innovación en el sector.
